Today, FAH submitted comments to the United States Trade Representative (USTR) urging an exemption for health care goods and products from the proposed tariffs on various goods from China, which will become effective on August […]
Read More… from FAH Urges USTR to Exempt Health Care Goods from China Tariffs
Ahead of tomorrow’s House Ways & Means Health Subcommittee hearing on “Improving Value-Based Care for Patients and Providers,” FAH is advocating for improved physician pay and against mandatory models as Congress considers an approach to […]
Today, FAH submitted feedback on the Senate Committee on Finance’s discussion draft of the “Medicare Drug Shortage Prevention and Mitigation Program.” The letter included FAH’s appreciation that Group Purchasing Organizations and wholesalers were included as […]
Read More… from FAH Questions the “Unintended Consequences” of Draft Drug Shortage Program
FAH provided comments to the Department of Justice Antitrust Division (DOJ), Department of Health and Human Services (HHS), and Federal Trade Commission (FTC) regarding the Request for Information on Consolidation in Health Care Markets. FAH comments […]
Read More… from FAH Highlights the Value of Integrated Health Systems to Administration
